Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction

Surgery

Volumn 148, Issue 1, 2010, Pages 31-38

  Yamamoto, Kazuyoshi ^a   Takiguchi, Shuji ^a   Miyata, Hiroshi ^a   Adachi, Shinichi ^a   Hiura, Yuichiro ^a   Yamasaki, Makoto ^a   Nakajima, Kiyokazu ^a   Fujiwara, Yoshiyuki ^a   Mori, Masaki ^a   Kangawa, Kenji ^b   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; PLACEBO;

ADULT; AGED; APPETITE; ARTICLE; BLOOD ANALYSIS; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOOD INTAKE; HUMAN; MALE; PERIOPERATIVE PERIOD; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STOMACH TUBE; WEIGHT CHANGE; WEIGHT REDUCTION;

AGED; BODY COMPOSITION; ENERGY INTAKE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GHRELIN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; STOMACH; WEIGHT LOSS;

EID: 77953287167     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.11.026     Document Type: Article

References (35)

1. Enzinger P.C. Mayer. RJ. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
2. De Leyn P., Coosemans W., and Lerut T. Early and late functional results in patients with intrathoracic gastric replacement after oesophagectomy for carcinoma. Eur J Cardiothorac Surg 6 (1992) 79-85
3. Martin L., Lagergren J., Lindblad M., Rouvelas I., and Lagergren P. Malnutrition after esophageal cancer surgery in Sweden. Br J Surg 94 (2007) 1496-1500
4. Martin L., Jia C., Rouvelas I., and Lagergren P. Risk factors for malnutrition after oesophageal and cardiac cancer surgery. Br J Surg 95 (2008) 1362-1368
5. Bozzetti F. Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17 (2009) 279-284
6. Odlund Olin A., Koochek A., Ljungqvist O., and Cederholm T. Nutritional status, well-being and functional ability in frail elderly service flat residents. Eur J Clin Nutr 59 (2005) 263-270
7. Bozzetti F., Gianotti L., Braga M., Di Carlo V., and Mariani L. Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26 (2007) 698-709
8. Kuwano H., Ikebe M., Baba K., Kitamura K., Toh Y., Matsuda H., et al. Operative procedures of reconstruction after resection of esophageal cancer and the postoperative quality of life. World J Surg 17 (1993) 773-776
9. Fein R., Kelsen D.P., Geller N., Bains M., McCormack P., and Brennan M.F. Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 56 (1985) 2512-2518
10. Bosaeus I., Daneryd P., and Lundholm K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132 11 Suppl (2002) 3465S-3466S
11. Ross P.J., Ashley S., Norton A., Priest K., Waters J.S., Eisen T., et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancer?. Br J Cancer 90 (2004) 1905-1911
12. Ludwig D.J., Thirlby R.C., and Low D.E. A prospective evaluation of dietary status and symptoms after near-total esophagectomy without gastric emptying procedure. Am J Surg 181 (2001) 454-458
13. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
14. Doki Y., Takachi K., Ishikawa O., Miyashiro I., Sasaki Y., Ohigashi H., et al. Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients. Surgery 139 (2006) 797-805
15. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
16. Van der Lely A.J., Tschop M., Heiman M.L., and Ghigo M. Biological physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrin Rev 25 (2004) 426-457
17. Korbonits M., Goldstone A.P., Gueorguiev M., and Grossman A.B. Ghrelin-a hormone with multiple functions. Front Neuroendocrinol 25 (2004) 27-68
18. Akamizu T., and Kangawa K. Translation research on the clinical applications of ghrelin. Endocrin J 53 (2006) 585-591
19. Ariyasu H., Iwakura H., Yamada G., Nakao K., Kangawa K., and Akamizu T. Efficacy of ghrelin as a therapeutic approach for age related physiological changes. Endocrinology 149 (2008) 3722-3728
20. Shintani M., Ogawa Y., Ebihara K., Aizawa M., Miyanaga F., Takaya K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50 (2001) 227-232
21. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., et al. Ghrelin enhances appetite and increases food intake in human. J Clin Endocrinol Metab 86 (2001) 5992-5995
22. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001) 1430-1435
23. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 86 (2001) 5854-5859
24. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 128 (2005) 1187-1193
25. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., et al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148 (2007) 3004-3012
26. Deboer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 149 (2008) 827-835
27. Akamizu T., Iwakura H., Ariyasu H., Hosoda H., Murayama T., Yokode M., et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol 158 (2008) 491-498
28. Akamizu T., Shinomiya T., Irako T., Fukunaga M., Nakai Y., Nakai Y., et al. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90 (2005) 6-9
29. Mazess R.B., Barden H.S., Bisek J.P., and Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 51 (1990) 1106-1112
30. Sobin L.H., and Wittekind C. TNM Classification of malignant tumours. 6th ed. (2002), John Wiley and Sons, Inc., New York
31. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
32. Irako T., Akamizu T., Hosoda H., Iwakura H., Ariyasu H., Tojo K., et al. Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats. Diabetologia 49 (2006) 1264-1273
33. Wu R., Dong W., Zhou M., Zhang F., Marini C.P., Ravikumar T.S., et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 176 (2007) 805-813
34. Martin S., Jesper L., and Weimin Y. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 44 (2008) 1566-1571
35. Baba M., Aikou T., Natsugoe S., Kusano C., Shimada M., Kimura S., et al. Appraisal of ten-year survival following esophagectomy for carcinoma of the esophagus with emphasis on quality of life. World J Surg 21 (1997) 282-286